Sponsor or institution
Clinical trials and research at Pierre Fabre Pharma GmbH
As of November 12, 2026, Find a Trial lists 2 clinical trials run by Pierre Fabre Pharma GmbH that are recruiting, at sites in 3 countries (most in Austria (2), Germany (2), Switzerland (1)). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 3Countries
All recruiting trials (2)
-
Investigation of Encorafenib and Cetuximab for BRAF-mutated Metastatic Colorectal Cancer
This study is testing if the combination of encorafenib and cetuximab can help people with advanced colorectal cancer that has a specific genetic mutation feel better and live longer after other treatments.
-
Investigation of encorafenib and binimetinib for advanced melanoma treatment
This study looks at how well the combination of encorafenib and binimetinib works for people with advanced melanoma who have a specific genetic mutation and have already tried other treatments.
Quick answers
How many clinical trials run by Pierre Fabre Pharma GmbH are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 3 countries. The most sites are in Austria (2 trials), Germany (2 trials), Switzerland (1 trial). Each study page lists its sites and which ones are recruiting.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.